Kanatani A, Ishihara A, Asahi S, Tanaka T, Ozaki S, Ihara M
Tsukuba Research Institute, Banyu Pharmaceutical Co., Japan.
Endocrinology. 1996 Aug;137(8):3177-82. doi: 10.1210/endo.137.8.8754736.
Neuropeptide Y (NPY) is thought to increase food intake through the action of Y1 (-like) receptors in the hypothalamus. To confirm the involvement of Y1 receptors in feeding behavior, selective and potent antagonists for Y1 receptors are required. In the present study, we showed that a peptide, 1229U91 [(Ile,Glu,Pro,Dpr,Tyr,Arg,Leu,Arg, Tyr-NH2)2 cyclic (2,4'),(2',4)-diamide], is a potent and selective antagonist for Y1 receptors. 1229U91 displaced [125I]peptide YY (PYY) binding to membranes of human neuroblastoma-derived SK-N-MC cells that predominantly express Y1 receptors with a K1 value 0.10 nM and inhibited the NPY-induced increase in intracellular calcium levels(IC50 = 0.27 nM). In contrast, the K1 values for [125I]PYY binding to Y2 receptors in membranes of human neuroblastoma-derived SK-N-BE2 cells and rat hypothalamus were 700 nM and more than 1 microM, respectively. Although [125I]PYY could not detect Y1 receptors in the rat hypothalamic membranes, [125I]1229U91 revealed binding sites with a high affinity (Kd = 18 pM), indicating the presence of Y1 receptors in the hypothalamus. Intracerebroventricular injection of 1229U91 (30 micrograms) into male Sprague-Dawley rats completely inhibited NPY (5 micrograms)-induced food intake without any other behavioral change. Furthermore, intracerebroventricular injection of 1229U91 significantly suppressed physiological feeding behavior after overnight fasting. These results indicate that Y1 receptors in the rat hypothalamus mediate NPY-induced food intake, and that physiological feeding behavior after overnight fasting may be largely regulated by NPY via Y1 receptors. 1229U91 may be useful for further elucidating the pathophysiological roles of NPY in feeding behavior.
神经肽Y(NPY)被认为通过下丘脑Y1(类)受体的作用增加食物摄入量。为了证实Y1受体参与摄食行为,需要Y1受体的选择性强效拮抗剂。在本研究中,我们表明一种肽,1229U91 [(异亮氨酸,谷氨酸,脯氨酸,D-脯氨酸,酪氨酸,精氨酸,亮氨酸,精氨酸,酪氨酸-NH2)2环(2,4'),(2',4)-二酰胺],是Y1受体的强效选择性拮抗剂。1229U91使[125I]肽YY(PYY)与主要表达Y1受体的人神经母细胞瘤来源的SK-N-MC细胞膜结合发生位移(K1值为0.10 nM),并抑制NPY诱导的细胞内钙水平升高(IC50 = 0.27 nM)。相比之下,[125I]PYY与人神经母细胞瘤来源的SK-N-BE2细胞和大鼠下丘脑膜中Y2受体结合的K1值分别为700 nM和超过1μM。虽然[125I]PYY无法检测大鼠下丘脑膜中的Y1受体,但[125I]1229U91显示出具有高亲和力的结合位点(Kd = 18 pM),表明下丘脑存在Y1受体。向雄性Sprague-Dawley大鼠脑室内注射1229U91(30微克)可完全抑制NPY(5微克)诱导的食物摄入,且无任何其他行为变化。此外,脑室内注射1229U91可显著抑制禁食过夜后的生理性摄食行为。这些结果表明,大鼠下丘脑的Y1受体介导NPY诱导的食物摄入,且禁食过夜后的生理性摄食行为可能在很大程度上由NPY通过Y1受体调节。1229U91可能有助于进一步阐明NPY在摄食行为中的病理生理作用。